foxo4 dri senolytic peptide animal model 2024 FOXO4-DRI Computational design of peptide targeting
Description
[DOI] [PubMed] [Google Scholar] 18
Similar to cagrilintide, pramlintide is primarily eliminated via the kidneys and, in a pharmacokinetic study in participants with type 1 diabetes, no statistically significant differences were noted in total (AUC 0- ) and peak ( C max ) exposure after administration of a single pramlintide 60 g dose in participants with mild, moderate or severe renal impairment compared with those with normal renal function, although inter-patient variability was high [20]
BPC-157 helps your body lay that scaffolding faster, tighter, and stronger
Diab Care 44 , 14331442 (2021)
